Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118368) titled 'Application of tandem mass spectrometry in early screening of neonatal G6PD deficiency: a retrospective case analysis' on Feb. 4.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Yuebei People's Hospital
Condition:
G6PD deficiency may lead to severe hyperbilirubinemia, and even result in bilirubin encephalopathy, which can cause neurological sequelae in newborns and even death.
Intervention:
Study group: All neonates diagnosed with G6PD deficiency by G6PD enzyme testing.:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-06
Target Sa...